Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Polomar Health Services
Los Angeles, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Polomar Health Services operates a licensed compounding pharmacy delivering commercial availability of customized medications for weight loss, diabetes, rheumatoid arthritis, erectile dysfunction, pulmonary hypertension, and dermatologic conditions. Products include compounded semaglutide, tofacitinib, sildenafil, and proprietary skin therapies. No clinical trials; products are prescription-based, pharmacy compounded, and generally use FDA-approved active ingredients.[1][2]
- Therapeutic areas
- CardiovascularImmunologyEndocrinologyMen's HealthDermatologyOncology
- Modalities
- Small moleculeBiologic
- Industry
- Non-Academic Healthcare
Beyond the preview
Go deeper on Polomar Health Services.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Polomar Health Services.